share_log

After Months Of Capital Crunch, Cannabis Company Lotus Ventures Completes Sale And Delisting

After Months Of Capital Crunch, Cannabis Company Lotus Ventures Completes Sale And Delisting

经过资本困境数月后,大麻股公司Lotus Ventures完成了销售和退市。
Benzinga ·  08/20 15:50

Cannabis company Lotus Ventures Inc. (OTC:LTTSF) (CSE:J) confirmed Monday that it has finalized a significant financial transaction. The Vancouver, Canada-based business sold 1,000 common shares to a purchaser, 5008679 Ontario Limited, for about CA$2.54 million ($1.87 million). Before this deal, the purchaser only owned about 6% of the company's shares.

大麻公司Lotus Ventures Inc. (OTC:LTTSF) (CSE:J)确认周一已经完成了一笔重要的金融交易。总部位于加拿大温哥华的企业向一个购买方5008679 Ontario Limited出售了1,000股普通股,价格约为CA$ 2,540,000元(187万美元)。在这笔交易之前,购买方仅持有公司股份的约6%。

Under the deal, all other existing shares of Lotus were canceled, meaning the purchaser now owns 100% of the company. Consequently, Lotus was removed (delisted) from the Canadian Stock Exchange (CSE) and the OTC Markets on August 20, 2024. The company also plans to request the removal of a cease trade order that was issued earlier this year and will cease to be a publicly reporting company in Alberta, British Columbia and Ontario.

根据交易,Lotus的所有其他现有股份被取消,这意味着购买方现在拥有该公司的100%股权。因此,Lotus于2024年8月20日被从加拿大证交所(CSE)和场外交易市场下市。该公司还计划要求撤销本年度早些时候发布的停牌命令,并将不再是阿尔伯塔省、不列颠哥伦比亚省和安大略省的上市公司。

Read Also: 'Inflationary Pressures Continue To Impact" Cannabis Industry, Says C21 As It Reports Net Loss And Decline In Nevada Sales

还要阅读: C21报告净亏损和内华达州销售下降后表示:“通胀压力继续影响”大麻行业

Money Issues

资金问题

In January, the company filed a Notice of Intention to Make a Proposal under the Bankruptcy and Insolvency Act concerning a certain loan. Since December, it has been evident that the company had money troubles, writes Green Market Report's Debra Borchardt. At the time, the company issued a statement confirming limited working capital.

该公司于1月根据破产法和破产法案提出了意向书,涉及某笔贷款。自去年12月以来,公司的资金问题已经显而易见,Green Market Report的Debra Borchardt写道。当时,公司发表声明,确认其工作资本有限。

"To reduce the working capital deficit, the company has negotiated a reduction of approximately $628K of its debt by issuing 25,141,640 shares at $0.025 per share with warrants at $0.05 per share expiring December 5, 2028," the company stated at the time. It also clarified that the amounts were in Canadian dollars.

“为了减少营运资本不足,公司已协商降低其债务约$628,000,发行每股$0.025的25,141,640股带有行权价为$0.05的认股权证,认股权期权到期日为2028年12月5日,”该公司当时声明。它还澄清,这些金额是以加元表示的。

The money troubles seem to have begun even earlier, with its earnings report for the fiscal year 2022 ending August 31, 2022, revealing revenue of CA$1.69 million ($1.25 million) in fiscal year, a 69% decrease compared to CA$5.48 million in the fiscal year 2021. The net loss at the time amounted to CA$4.79 million, compared to income of CA$241,097 in the prior year.

资金问题似乎更早就开始了,截至2022年8月31日结束的2022财年的收入报告显示,财年营业收入为CA $1.69 million(125万美元),较2021财年的CA $5.48 million(500万美元)下降了69%。当时的净损失金额为CA $4.79 million(355万美元),而上一年度的收入为CA $241,097(17.9万美元)。

  • PharmaCielo Cannabis Co. Sees 390% YoY Revenue Jump As Losses Narrow In Q2 2024
  • PharmaCielo大麻股公司2014年第二季度营收同比增长390%,亏损减少。

Photo: Courtesy of Artem Avetisyan via Shutterstock

照片:由Shutterstock的Artem Avetisyan提供

big
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发